CLVLY Projected Dividend Yield
ADR (Sponsored)/Clinuvel Pharmaceuticals Ltd. ( OTCBB : CLVLY )Clinuvel Pharmaceuticals is a biopharmaceutical company focussed on developing and delivering treatments for patients with a range of genetic and skin disorders. Co.'s research and development is focussed on treatments for patient populations with a clinical need for photoprotection and repigmentation. Co. is focused on developing and commercialising SCENESSE® as a preventative therapy to photo-protect patients with erythropoietic protoporphyria. Co. is also focused on developing and commercializing SCENESSE® as a combination therapy with narrowband ultraviolet B phototherapy for patients with vitiligo. Co. has operations in Europe, Singapore and the United States. 29 YEAR PERFORMANCE RESULTS |
CLVLY Dividend History Detail CLVLY Dividend News CLVLY Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
2024 |
N/A |
Sep 09, 2024 |
Sep 09, 2024 |
Sep 30, 2024 |
0.0299 |
2024 Total: |
0.0299 |
||||
2023 |
N/A |
Sep 07, 2023 |
Sep 08, 2023 |
Oct 02, 2023 |
0.0285 |
2023 Total: |
0.0285 |
||||
2022 |
N/A |
Sep 09, 2022 |
Sep 12, 2022 |
Oct 03, 2022 |
0.0235 |
2022 Total: |
0.0235 |
||||
2021 |
N/A |
Sep 03, 2021 |
Sep 07, 2021 |
Sep 27, 2021 |
0.0136 |
2021 Total: |
0.0136 |
||||
2020 |
N/A |
Sep 04, 2020 |
Sep 08, 2020 |
Sep 28, 2020 |
0.0136 |
2020 Total: |
0.0136 |